Global Vaccines & Vaccination Summit & B2B
November 01-02, 2017 | Toronto, Canada
Keynote
-
Autoimmunity in breast carcinogenesis: Implications for vaccination in solid tumors
Ann Clin Trials Vaccines Res
Felix Fernandez Madrid -
Can mucosal immunity succeed where other systemic immune responses failed? Intranasal immunization using a NanostatTM platform technology protected against respiratory and sexually transmitted diseases in the appropriate animal challenge models
Ann Clin Trials Vaccines Res
Ali Fattom -
Colon cancer stem cell-based vaccine reduces efficiently both tumour growth and cancer stem cell subpopulation in a mouse colon carcinoma model
Ann Clin Trials Vaccines Res
Jun Dou -
Community engagement in HIV vaccine research as a treatment strategy among men who have sex with men (MSM)
Ann Clin Trials Vaccines Res
Kelvin Owange Otieno -
Measles vaccination: Threat from related veterinary viruses and need for continued vaccination post measles eradication
Ann Clin Trials Vaccines Res
S Louise Cosby -
Feasibility of monitoring cell mediated immunity during vaccine trials
Ann Clin Trials Vaccines Res
Magdalena Tary-Lehmann -
Recent progress in human mucosal vaccine development: Role of mucosal immunity and mucosal microbiome in the outcome of vaccine effectiveness
Ann Clin Trials Vaccines Res
Pearay L Ogra -
The Brazilian national immunization program and its challenges for modernization and improvement
Ann Clin Trials Vaccines Res
Ricardo Bordinhao -
Universal viral vectors for prophylactic vaccines against infectious diseases and for therapeutic vaccines against persistent viral infections
Ann Clin Trials Vaccines Res
Chil-Yong Kang